This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Masarykova Univerzita. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Marketa Kaucka: Innovator in Chronic Lymphocytic Leukemia Research
Introduction
Marketa Kaucka is a prominent inventor based in Hradec Králové, Czech Republic. She has made significant contributions to the field of medical research, particularly in the diagnosis and prognosis of B-cell chronic lymphocytic leukemia (CLL). Her innovative work has led to the development of a patented method that enhances the understanding of this complex disease.
Latest Patents
Marketa Kaucka holds a patent titled "Method of determination of diagnosis and prognosis in patients with B-cell chronic lymphocytic leukemia and oligonucleotides for use in this method." This invention provides a method for determining the diagnosis and prognosis of CLL from a biological sample collected from a patient. The method focuses on assessing the status of the Wnt/PCP signaling pathway, which is crucial in understanding the molecular mechanisms underlying CLL. The invention identifies the relationship between CLL and the Wnt/PCP signaling pathway, highlighting components that are significantly up-regulated in B-lymphocytes of affected patients. The status of this signaling pathway can be determined through various techniques, including the expression analysis of its components and the migration assessment of CLL cells in response to chemokines.
Career Highlights
Marketa Kaucka is affiliated with Masaryk University, where she continues her research and innovation in the field of oncology. Her work has not only advanced scientific knowledge but also holds the potential for improving patient outcomes in CLL.
Collaborations
Throughout her career, Marketa has collaborated with esteemed colleagues such as Pavel Krejci and Jana Kotaskova. These partnerships have fostered a collaborative environment that enhances research productivity and innovation.
Conclusion
Marketa Kaucka's contributions to the field of chronic lymphocytic leukemia research exemplify the impact of innovative thinking in medicine. Her patented method represents a significant advancement in the diagnosis and prognosis of this disease, showcasing her dedication to improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile